Clinical Trial Update: A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough [Phase 4]

View source ↗

Summary

Phase 4 randomized open-label 2x2 factorial trial evaluating neuromodulators and cough control therapy for refractory or unexplained chronic cough. Recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough
• Cough Hypersensitivity Syndrome

Snippet

Sponsor: McMaster University | Conditions: Cough, Refractory Chronic Cough | Phase 4 | Status: NOT_YET_RECRUITING